Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FUN14 domain-containing protein 1 is an **outer mitochondrial membrane protein** that acts as a **receptor for mitophagy**, the selective autophagic clearance of damaged mitochondria[7][4][1]. It contains three α-helical transmembrane domains, with its LIR motif binding directly to the autophagy protein LC3, thus initiating mitophagy especially under hypoxic or stress conditions[7]. FUNDC1 plays a central role in maintaining mitochondrial quality and cellular health, linking mitochondrial dynamics (fission/fusion) and apoptotic regulation. It also contributes to the formation of mitochondria-associated endoplasmic reticulum membranes (MAMs), impacting processes such as calcium signaling and angiogenesis[3]. **Dysfunction or altered expression of FUNDC1** is implicated in cardiovascular disease, cancer, and metabolic disorders, and its activity is tightly regulated by phosphorylation and ubiquitination[1][6][7]. Although not a traditional drug target, its central role in mitochondrial homeostasis represents a potential therapeutic avenue for conditions driven by mitophagy imbalance.
Agents that affect FUNDC1 typically act by modulating its phosphorylation/dephosphorylation or ubiquitination, thereby regulating mitophagy activity[1][7]. Indirect mechanisms may involve influencing interactions with proteins such as LC3 (binding through the LIR motif), DRP1 (regulating mitochondrial fission), or elements of the endoplasmic reticulum.[7][3]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FUN14 domain-containing protein 1 (FUNDC1).